Evaluation of liver fibrosis and carotid intima-media thickness index (C-IMT) in patients with chronic hepatitis C virus before and after direct-acting antiviral treatment (DAA)

Introduction. Viral hepatitis is still a challenge for the medical world and research over the past decades has been aimed at discovering viable methods of prevention, diagnosis and treatment. Material and methods. Data analysed from 73 patients from ”Dr. Victor Babes” Clinical Hospital of Infectio...

Full description

Bibliographic Details
Main Authors: Raluca Mihaela Dirtu, George Sebastian Gherlan, Daniel Codreanu, Valentina Simion, Horia Nicolae, Corneliu Petru Popescu, Simin Aysel Florescu, Emanoil Ceausu, Petre Iacob Calistru
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2021-06-01
Series:Romanian Journal of Infectious Diseases
Subjects:
Online Access:https://rjid.com.ro/articles/2021.2/RJID_2021_2_Art-07.pdf
_version_ 1828349183108579328
author Raluca Mihaela Dirtu
George Sebastian Gherlan
Daniel Codreanu
Valentina Simion
Horia Nicolae
Corneliu Petru Popescu
Simin Aysel Florescu
Emanoil Ceausu
Petre Iacob Calistru
author_facet Raluca Mihaela Dirtu
George Sebastian Gherlan
Daniel Codreanu
Valentina Simion
Horia Nicolae
Corneliu Petru Popescu
Simin Aysel Florescu
Emanoil Ceausu
Petre Iacob Calistru
author_sort Raluca Mihaela Dirtu
collection DOAJ
description Introduction. Viral hepatitis is still a challenge for the medical world and research over the past decades has been aimed at discovering viable methods of prevention, diagnosis and treatment. Material and methods. Data analysed from 73 patients from ”Dr. Victor Babes” Clinical Hospital of Infectious and Tropical Diseases and ”Dr. Victor Babes” Private Medical Clinic, both from Bucharest. Results. Fibroscan assessment showed that patients predominantly have F2, F3, F4 Metavir fibrosis stage while FibroTest showed F3, F4 stage of fibrosis. It was observed a decrease in fibrosis stage after DAA treatment comparative to values before treatment (5.622 kPa average post-treatment comparative to 11.49 kPa before treatment, statistically significant with p value < 0.001). Chronic infection with hepatitis C virus is considered a risk factor for atherosclerosis correlated with a higher cardiovascular risk compared to the general population. Monitoring patients prior to and after DAA treatment is an efficient method to detect early vascular changes that could lead to thrombotic and/or cardiovascular events. Conclusions. Measurement of the IMT index by doppler ultrasound in patients with hepatitis C virus infectionmay constitute a method of identification the endothelial dysfunction or atherosclerosis and may help to establish cardiovascular risk. Elimination of hepatitis C virus is the target of ongoing international programmes but the extrahepatic effects of persistent infection, early diagnosis and appropriate treatment should not be neglected.
first_indexed 2024-04-14T01:05:51Z
format Article
id doaj.art-ea0ba01e9bc44517a9dab52f8f304f01
institution Directory Open Access Journal
issn 1454-3389
2069-6051
language English
last_indexed 2024-04-14T01:05:51Z
publishDate 2021-06-01
publisher Amaltea Medical Publishing House
record_format Article
series Romanian Journal of Infectious Diseases
spelling doaj.art-ea0ba01e9bc44517a9dab52f8f304f012022-12-22T02:21:16ZengAmaltea Medical Publishing HouseRomanian Journal of Infectious Diseases1454-33892069-60512021-06-0124210310810.37897/RJID.2021.2.7Evaluation of liver fibrosis and carotid intima-media thickness index (C-IMT) in patients with chronic hepatitis C virus before and after direct-acting antiviral treatment (DAA)Raluca Mihaela Dirtu0George Sebastian Gherlan1Daniel Codreanu2Valentina Simion3Horia Nicolae4Corneliu Petru Popescu5Simin Aysel Florescu6Emanoil Ceausu7Petre Iacob Calistru8“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; “Dr. Victor Babes” Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; “Dr. Victor Babes” Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania; “Dr. Victor Babes” Private Medical Clinic, Bucharest, Romania“Dr. Victor Babes” Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; “Dr. Victor Babes” Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Elias University Emergency Hospital, Bucharest, Romania“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; “Dr. Victor Babes” Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; “Dr. Victor Babes” Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; “Dr. Victor Babes” Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania; Academy of Medical Sciences, Romania“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; “Dr. Victor Babes” Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania; “Dr. Victor Babes” Private Medical Clinic, Bucharest, RomaniaIntroduction. Viral hepatitis is still a challenge for the medical world and research over the past decades has been aimed at discovering viable methods of prevention, diagnosis and treatment. Material and methods. Data analysed from 73 patients from ”Dr. Victor Babes” Clinical Hospital of Infectious and Tropical Diseases and ”Dr. Victor Babes” Private Medical Clinic, both from Bucharest. Results. Fibroscan assessment showed that patients predominantly have F2, F3, F4 Metavir fibrosis stage while FibroTest showed F3, F4 stage of fibrosis. It was observed a decrease in fibrosis stage after DAA treatment comparative to values before treatment (5.622 kPa average post-treatment comparative to 11.49 kPa before treatment, statistically significant with p value < 0.001). Chronic infection with hepatitis C virus is considered a risk factor for atherosclerosis correlated with a higher cardiovascular risk compared to the general population. Monitoring patients prior to and after DAA treatment is an efficient method to detect early vascular changes that could lead to thrombotic and/or cardiovascular events. Conclusions. Measurement of the IMT index by doppler ultrasound in patients with hepatitis C virus infectionmay constitute a method of identification the endothelial dysfunction or atherosclerosis and may help to establish cardiovascular risk. Elimination of hepatitis C virus is the target of ongoing international programmes but the extrahepatic effects of persistent infection, early diagnosis and appropriate treatment should not be neglected.https://rjid.com.ro/articles/2021.2/RJID_2021_2_Art-07.pdfhepatitis virus cimtcardiovascularextrahepaticdaa
spellingShingle Raluca Mihaela Dirtu
George Sebastian Gherlan
Daniel Codreanu
Valentina Simion
Horia Nicolae
Corneliu Petru Popescu
Simin Aysel Florescu
Emanoil Ceausu
Petre Iacob Calistru
Evaluation of liver fibrosis and carotid intima-media thickness index (C-IMT) in patients with chronic hepatitis C virus before and after direct-acting antiviral treatment (DAA)
Romanian Journal of Infectious Diseases
hepatitis virus c
imt
cardiovascular
extrahepatic
daa
title Evaluation of liver fibrosis and carotid intima-media thickness index (C-IMT) in patients with chronic hepatitis C virus before and after direct-acting antiviral treatment (DAA)
title_full Evaluation of liver fibrosis and carotid intima-media thickness index (C-IMT) in patients with chronic hepatitis C virus before and after direct-acting antiviral treatment (DAA)
title_fullStr Evaluation of liver fibrosis and carotid intima-media thickness index (C-IMT) in patients with chronic hepatitis C virus before and after direct-acting antiviral treatment (DAA)
title_full_unstemmed Evaluation of liver fibrosis and carotid intima-media thickness index (C-IMT) in patients with chronic hepatitis C virus before and after direct-acting antiviral treatment (DAA)
title_short Evaluation of liver fibrosis and carotid intima-media thickness index (C-IMT) in patients with chronic hepatitis C virus before and after direct-acting antiviral treatment (DAA)
title_sort evaluation of liver fibrosis and carotid intima media thickness index c imt in patients with chronic hepatitis c virus before and after direct acting antiviral treatment daa
topic hepatitis virus c
imt
cardiovascular
extrahepatic
daa
url https://rjid.com.ro/articles/2021.2/RJID_2021_2_Art-07.pdf
work_keys_str_mv AT ralucamihaeladirtu evaluationofliverfibrosisandcarotidintimamediathicknessindexcimtinpatientswithchronichepatitiscvirusbeforeandafterdirectactingantiviraltreatmentdaa
AT georgesebastiangherlan evaluationofliverfibrosisandcarotidintimamediathicknessindexcimtinpatientswithchronichepatitiscvirusbeforeandafterdirectactingantiviraltreatmentdaa
AT danielcodreanu evaluationofliverfibrosisandcarotidintimamediathicknessindexcimtinpatientswithchronichepatitiscvirusbeforeandafterdirectactingantiviraltreatmentdaa
AT valentinasimion evaluationofliverfibrosisandcarotidintimamediathicknessindexcimtinpatientswithchronichepatitiscvirusbeforeandafterdirectactingantiviraltreatmentdaa
AT horianicolae evaluationofliverfibrosisandcarotidintimamediathicknessindexcimtinpatientswithchronichepatitiscvirusbeforeandafterdirectactingantiviraltreatmentdaa
AT corneliupetrupopescu evaluationofliverfibrosisandcarotidintimamediathicknessindexcimtinpatientswithchronichepatitiscvirusbeforeandafterdirectactingantiviraltreatmentdaa
AT siminayselflorescu evaluationofliverfibrosisandcarotidintimamediathicknessindexcimtinpatientswithchronichepatitiscvirusbeforeandafterdirectactingantiviraltreatmentdaa
AT emanoilceausu evaluationofliverfibrosisandcarotidintimamediathicknessindexcimtinpatientswithchronichepatitiscvirusbeforeandafterdirectactingantiviraltreatmentdaa
AT petreiacobcalistru evaluationofliverfibrosisandcarotidintimamediathicknessindexcimtinpatientswithchronichepatitiscvirusbeforeandafterdirectactingantiviraltreatmentdaa